118. 脊髄髄膜瘤 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 6 / 薬物数 : 9 - (DrugBank : 4) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 12
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Anticholinergic
Assiut University
2024 - NCT06301802 Egypt
Atosiban
University of Sao Paulo General Hospital
2017 - NCT04468568 Brazil
Botulinum A toxin
University of Aarhus
2005 Phase 4 NCT00175123 Denmark
CIC
Assiut University
2024 - NCT06301802 Egypt
Contrast enhanced voiding urosonography with urodynamic testing
University of Virginia
2021 - NCT04738539 United States
Monitor
Marmara University
2016 - NCT04186338 -
Placental mesenchymal stem cells seeded ON A commercially available dural graft extracellular matrix
University of California, Davis
2021 Phase 1/Phase 2 NCT04652908 United States
Terbutaline
University of Sao Paulo General Hospital
2017 - NCT04468568 Brazil
Untreated contemporaneous cohort
University of California, Davis
2021 Phase 1/Phase 2 NCT04652908 United States
Assiut University
2024 - NCT06301802 Egypt
Atosiban
University of Sao Paulo General Hospital
2017 - NCT04468568 Brazil
Botulinum A toxin
University of Aarhus
2005 Phase 4 NCT00175123 Denmark
CIC
Assiut University
2024 - NCT06301802 Egypt
Contrast enhanced voiding urosonography with urodynamic testing
University of Virginia
2021 - NCT04738539 United States
Monitor
Marmara University
2016 - NCT04186338 -
Placental mesenchymal stem cells seeded ON A commercially available dural graft extracellular matrix
University of California, Davis
2021 Phase 1/Phase 2 NCT04652908 United States
Terbutaline
University of Sao Paulo General Hospital
2017 - NCT04468568 Brazil
Untreated contemporaneous cohort
University of California, Davis
2021 Phase 1/Phase 2 NCT04652908 United States